Matches in SemOpenAlex for { <https://semopenalex.org/work/W2413723193> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W2413723193 endingPage "63" @default.
- W2413723193 startingPage "555" @default.
- W2413723193 abstract "We present the results on Anaemia Management in Fresenius Medical Care Spain dialysis centres as reported by EuCliD (European Clinical Database), evaluating a population of 4,426 patients treated in Spain during the year 2001. To analyse the erythropoietin dose and the haemoglobin levels we divided the population in two groups according to the time with dialysis treatment: patients treated less than six months and patients between six months, and four years on therapy. We compared our results with the evidence based recommendations Guidelines: the European Best Practice Guidelines (EBPG) and the US National Kidney Foundation (NKF-K/DOQI). We also compared our results with those presented by the ESAM2 on 2,618 patients on dialysis in Spain carried out in the second half of the year 2000. We observed that 70% of the population reaches an haemoglobin value higher that 11 g/dl, with a mean erythropoietin (rHu-EPO) dose of 111.9 Ul/kg weight/week (n = 3,700; SD 74.9). However, for those patients on treatment for less than six months, the mean Haemoglobin only reaches 10.65 g/dl (n = 222; SD 1.4). The rHu-EPO was administrated subcutaneously in 70.2% of the patients. About the iron therapy, 86% of the patients received iron treatment and the administration route was intravenous in 93% of the population. The ferritin levels were below 100 micrograms/dl in 10% of the patients and 26.4% showed a transferrin saturation index (TSAT) below 20%. The erythropoieting resistance index (ERI), as rHu-EPO/haemoglobin, has been used to evaluate the response to rHu-Epo, according to different variables. It was observed that the following factors lead to a higher rHu-EPO resistance: intravenous rHu-EPO as administration route, the presence of hypoalbuminemia, increase of protein C reactive, Transferrin saturation below 20% and starting dialysis during the last six months." @default.
- W2413723193 created "2016-06-24" @default.
- W2413723193 creator A5027429510 @default.
- W2413723193 creator A5042578609 @default.
- W2413723193 creator A5056500253 @default.
- W2413723193 creator A5064574377 @default.
- W2413723193 creator A5066133025 @default.
- W2413723193 creator A5075437839 @default.
- W2413723193 creator A5080548314 @default.
- W2413723193 date "2002-01-01" @default.
- W2413723193 modified "2023-09-23" @default.
- W2413723193 title "[Anemia management in haemodialysis. EuCliD database in Spain]." @default.
- W2413723193 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12516289" @default.
- W2413723193 hasPublicationYear "2002" @default.
- W2413723193 type Work @default.
- W2413723193 sameAs 2413723193 @default.
- W2413723193 citedByCount "0" @default.
- W2413723193 crossrefType "journal-article" @default.
- W2413723193 hasAuthorship W2413723193A5027429510 @default.
- W2413723193 hasAuthorship W2413723193A5042578609 @default.
- W2413723193 hasAuthorship W2413723193A5056500253 @default.
- W2413723193 hasAuthorship W2413723193A5064574377 @default.
- W2413723193 hasAuthorship W2413723193A5066133025 @default.
- W2413723193 hasAuthorship W2413723193A5075437839 @default.
- W2413723193 hasAuthorship W2413723193A5080548314 @default.
- W2413723193 hasConcept C126322002 @default.
- W2413723193 hasConcept C141071460 @default.
- W2413723193 hasConcept C153852466 @default.
- W2413723193 hasConcept C187212893 @default.
- W2413723193 hasConcept C2777417653 @default.
- W2413723193 hasConcept C2778248108 @default.
- W2413723193 hasConcept C2778319317 @default.
- W2413723193 hasConcept C2778534260 @default.
- W2413723193 hasConcept C2779978075 @default.
- W2413723193 hasConcept C2908647359 @default.
- W2413723193 hasConcept C3019433959 @default.
- W2413723193 hasConcept C71924100 @default.
- W2413723193 hasConcept C99454951 @default.
- W2413723193 hasConceptScore W2413723193C126322002 @default.
- W2413723193 hasConceptScore W2413723193C141071460 @default.
- W2413723193 hasConceptScore W2413723193C153852466 @default.
- W2413723193 hasConceptScore W2413723193C187212893 @default.
- W2413723193 hasConceptScore W2413723193C2777417653 @default.
- W2413723193 hasConceptScore W2413723193C2778248108 @default.
- W2413723193 hasConceptScore W2413723193C2778319317 @default.
- W2413723193 hasConceptScore W2413723193C2778534260 @default.
- W2413723193 hasConceptScore W2413723193C2779978075 @default.
- W2413723193 hasConceptScore W2413723193C2908647359 @default.
- W2413723193 hasConceptScore W2413723193C3019433959 @default.
- W2413723193 hasConceptScore W2413723193C71924100 @default.
- W2413723193 hasConceptScore W2413723193C99454951 @default.
- W2413723193 hasIssue "6" @default.
- W2413723193 hasLocation W24137231931 @default.
- W2413723193 hasOpenAccess W2413723193 @default.
- W2413723193 hasPrimaryLocation W24137231931 @default.
- W2413723193 hasRelatedWork W1892409238 @default.
- W2413723193 hasRelatedWork W1997022539 @default.
- W2413723193 hasRelatedWork W2019494479 @default.
- W2413723193 hasRelatedWork W2036118269 @default.
- W2413723193 hasRelatedWork W2186642052 @default.
- W2413723193 hasRelatedWork W2389206417 @default.
- W2413723193 hasRelatedWork W2413723193 @default.
- W2413723193 hasRelatedWork W2626510945 @default.
- W2413723193 hasRelatedWork W338088 @default.
- W2413723193 hasRelatedWork W72680060 @default.
- W2413723193 hasVolume "22" @default.
- W2413723193 isParatext "false" @default.
- W2413723193 isRetracted "false" @default.
- W2413723193 magId "2413723193" @default.
- W2413723193 workType "article" @default.